Exploring the mechanism of α-Bisabolol in the treatment of psoriasis based on network pharmacology and experimental validation
- 13 March 2025
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 999, 177433
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Network pharmacology approach and molecular docking to explore the potential mechanism of Wu-Wei-Wen-Tong Chubi capsules in rheumatoid arthritisNaunyn-Schmiedeberg's Archives of Pharmacology, 2022
- Pharmacological effects of a complex α-bisabolol/β-cyclodextrin in a mice arthritis model with involvement of IL-1β, IL-6 and MAPKBiomedicine & Pharmacotherapy, 2022
- Evaluation of the benefit of thermal spa therapy in plaque psoriasis: the PSOTHERMES randomized clinical trialInternational Journal of Biometeorology, 2022
- α-Bisabolol suppresses the inflammatory response and ECM catabolism in advanced glycation end products-treated chondrocytes and attenuates murine osteoarthritisInternational Immunopharmacology, 2020
- Effect of (-)-α-Bisabolol on the Inflammatory Response in Systemic Infection Experimental Model in C57BL/6 MiceInflammation, 2019
- Pharmacological interaction of α‐bisabolol and diclofenac on nociception, inflammation, and gastric integrity in ratsDrug Development Research, 2017
- Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathwayInternational Immunopharmacology, 2016
- Ligand docking and binding site analysis with PyMOL and Autodock/VinaJournal of Computer-Aided Molecular Design, 2010
- Interplay between keratinocytes and immune cells—Recent insights into psoriasis pathogenesisThe International Journal of Biochemistry & Cell Biology, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009